Importance Results show the short-term risk of hemorrhage in treating patients with acute
transient ischemic attack (TIA) or minor acute ischemic stroke (AIS) with clopidogrel plus …

Importance Dual antiplatelet therapy with clopidogrel and aspirin is effective for secondary
prevention after minor ischemic stroke or transient ischemic attack (TIA). Uncertainties …

Background Stroke is common during the first few weeks after a transient ischemic attack
(TIA) or minor ischemic stroke. Combination therapy with clopidogrel and aspirin may …

Background: In patients with acute minor ischemic stroke or high-risk transient ischemic
attack enrolled in the POINT trial (Platelet-Oriented Inhibition in New TIA and Minor Ischemic …

Background: Aspirin plus clopidogrel (A+ C) may be more effective than aspirin only (AO)
acutely after TIA and minor stroke, but the risk of bleeding in the acute phase is uncertain …

Objective: To investigate the short-term time course risks and benefits of clopidogrel with
aspirin in minor ischemic stroke or TIA. Methods: Data were derived from the Clopidogrel in …

Background The aim of this study was to analyze the benefits and safety associated with the
combination therapy of clopidogrel and aspirin among minor stroke or transient ischemic …

Background Ischemic stroke and other vascular outcomes occur in 10–20% of patients in the
three-months following a transient ischemic attack or minor ischemic stroke, and many are …

Background Combination antiplatelet therapy with clopidogrel and aspirin may reduce the
rate of recurrent stroke during the first 3 months after a minor ischemic stroke or transient …

Background—The Clopidogrel in High-risk patients with Acute Non-disabling
Cerebrovascular Events (CHANCE) trial showed that the combined treatment of clopidogrel …